Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Unmet needs in RCC

Laurence Albiges • 22 May 2020
ASCO 2020
Genitourinary Cancer

Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France, reviews the emerging unmet needs in renal cell carcinoma, and the ideal sequential strategy in the post-immunotherapy space. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Laurence Albiges

2:48
LITESPARK-005: Belzutifan versus everolimus in ccRCC
Laurence Albiges • 21 Oct 2023
4:21
Biomarker development in RCC and UC
Laurence Albiges • 23 Sep 2021
2:24
Current and emerging treatment strategies for patients with mccRCC
Laurence Albiges • 23 Sep 2021
1:50
BIONIKK: the first trial study in mccRCC
Laurence Albiges • 18 Sep 2020

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals